Disclosure of Conflict of Interest
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), National Jewish Health requires that all program faculty, content developers, reviewers, and others in a position to control the content of this activity disclose to learners the presence or absence of any relevant financial relationships with an ACCME-defined ineligible company within the preceding 24 months of the activity. The ACCME defines an “ineligible company” as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Our goal is to ensure that there is no compromise in the ethical relationship that exists between those in a position to control the content of the activity and those participating in the activity and their respective professional duties. All accredited education activities offered by National Jewish Health are reviewed to ensure a balanced and evidence-based presentation.
All relevant financial relationships among individuals in a position to control the content of this activity have been identified and mitigated according to the Standards of Integrity and Independence in Accredited Continuing Education.
Faculty Disclosures
Charles Daley, MD (Program Co-Director) discloses he is on an advisory board for Insmed, Paratek, Spero, AN2 Therapeutics, and Matinas. He is also an investigator for Insmed and BugWorks.
Shannon H. Kasperbauer, MD (Program Co-Director) discloses she is a speaker for Paratek and on an advisory board for Insmed and AN2 Therapeutics.
Edward D. Chan, MD has no relevant financial relationships to disclose.
Keira Cohen, MD discloses she is on an advisory board for Insmed and HillRom, Inc. and a consultant for Microbion.
Jared Eddy, MD has no relevant financial relationships to disclose.
David Griffith, MD discloses he is a consultant for Insmed, AN2 Therapeutics and Spero.
Jennifer R. Honda, PhD has no relevant financial relationships to disclose.
Gwen Huitt, MD discloses she is a speaker for Insmed.
Reeti Khare, PhD has no relevant financial relationships to disclose.
Tilman L. Koelsch, MD has no relevant financial relationships to disclose.
Amy Leitman, JD has no relevant financial relationships to disclose.
Steven Lommatzsch, MD discloses he is an investigator for Insmed.
Stacey Martiniano, MD discloses she is on a data safety monitoring board for Beyond Air.
John Mitchell, MD discloses he is a consultant for Intuitive Surgical, Inc.
Rebecca Prevots, PhD has no relevant financial relationships to disclose.
Michael Strong, PhD has no relevant financial relationships to disclose
Planner/Reviewer Disclosures
Meghan Brenner, MA has no relevant financial relationships to disclose.
Edward D. Chan, MD has no relevant financial relationships to disclose.
Charles Daley, MD (Program Co-Director) discloses he is on an advisory board for Insmed, Paratek, Spero, AN2 Therapeutics, and Matinas. He is also an investigator for Insmed and BugWorks.
Andrea Harshman, MHA, CHCP, CMP-HC has no relevant financial relationships to disclose.
Jennifer R.Honda, PhD has no relevant financial relationships to disclose.
Shannon H. Kasperbauer, MD (Program Co-Director) discloses she is a speaker for Paratek and on an advisory board for Insmed and AN2 Therapeutics.
Reeti Khare, PhD has no relevant financial relationships to disclose.
Ann Mullen, RN, CNS, CDE, AE-C has no relevant financial relationships to disclose.
Harold Nelson, MD discloses he is a consultant for ALK and on a data safety monitoring board for AstraZeneca.
Lauren Rieck, MBA has no relevant financial relationships to disclose.
Nicholas Walter, MD has no relevant financial relationships to disclose.
Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses.
Please refer to the official prescribing information for each product for discussion of approved indicators, contraindications and warnings.
Disclaimer
National Jewish Health (“NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.
By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.
Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.
